Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,8413,860 of 20,252 grants

Completed OTHER RESEARCH-RELATED
Countering E-cigarette Marketing in the Retail Environment among Adolescents and Young Adults
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2023

PROJECT SUMMARY/ ABSTRACT Despite significant efforts to limit youth from accessing and using electronic cigarettes (e-cigarettes), many adolescents and young adults are directly p...

$612.2K
USD
Active OTHER RESEARCH-RELATED
Defining pro-metastatic and endothelial-regulatory roles for LIN28B in hepatocellular carcinoma
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2027

PROJECT SUMMARY Hepatocellular carcinoma (HCC) is a lethal solid tumor that is highly dependent on recruitment of new blood vessels and has no common genomic targets. As for most s...

$2.65M
USD
Completed OTHER RESEARCH-RELATED
Traditional and New Dietary Assessment Methods (TANDAM) for Personalized Nutrition
NATIONAL CANCER INSTITUTE University of Hawaii At Manoa United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Errors in dietary assessment methods attenuate the association between diet and chronic disease outcomes, such as obesity and cancer, which derails efforts...

$4.41M
USD
Completed SBIR-STTR RPGS
A Novel Melanoma Vaccine Based on a Shared Neoantigen and a Liquid Polymer Platform
NATIONAL CANCER INSTITUTE Trekka Therapeutics, Llc United States 2023 – 2024

Abstract Despite the dramatic improvement in outcomes afforded by immune checkpoint inhibitors and targeted therapies, most patients with metastatic BRAF-mutated melanoma ultimatel...

$1.48M
USD
Active NON-SBIR/STTR RPGS
Sulindac sensitizes colorectal cancer to anti-PD-L1 therapy
NATIONAL CANCER INSTITUTE University of Georgia United States 2023 – 2027

Project Summary: The overall survival of colorectal cancer (CRC) patients has improved significantly over the past few decades, but the 5-year survival rate for patients with stage...

$5.63M
USD
Active NON-SBIR/STTR RPGS
Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2023 – 2027

Project Summary/Abstract Therapies against immunologic checkpoint proteins, such as PD-L1, have revolutionized the treatment of multiple malignancies, such as malignant melanoma, l...

$2.01M
USD
Completed NON SBIR/STTR CONTRACTS
SEER TRAINING WEBSITE, NEW DATA ITEM FEASIBILITY STUDY, AND SEER ADVANCED TOPICS FOR REGISTRY PROFESSIONALS WORKSHOP TECHNICAL AND LOGISTICAL SUPPORT
NATIONAL CANCER INSTITUTE National Cancer Registrar'S Association United States 2023 – 2024

TECHNICAL AND LOGISTICAL SUPPORT for -SEER TRAINING WEBSITE, -NEW DATA ITEM FEASIBILITY STUDY, -AND SEER ADVANCED TOPICS FOR REGISTRY PROFESSIONALS WORKSHOP

$1.41M
USD
Active NON-SBIR/STTR RPGS
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT This R01 proposal aims to test the effectiveness, mechanism, and implementation of a navigation-based multilevel intervention to improve the delivery of ti...

$6.55M
USD
Active TRAINING, INDIVIDUAL
HMGB1 in EB-Associated Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2027

Project Summary/Abstract Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genetic disease characterized by chronic wounds and shortened lifespan due to a high incidence...

$351.6K
USD
Active NON-SBIR/STTR RPGS
Therapy-induced cognitive impairment in a rat model of prostate cancer
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2023 – 2028

Androgen deprivation therapy (ADT) is a mainstay of prostate cancer treatment. However, ADT has adverse effects, including cognitive impairment that compromises quality of life for...

$3.91M
USD
Active NON-SBIR/STTR RPGS
LncRNA EPIC1 induces immunotherapy resistance by activating EZH2 in breast cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

Summary:On July 26, 2021, the FDA approved the anti-PD1 immunotherapy pembrolizumab (Keytruda®, Merck) for triple negative breast cancer (TNBC) patients. Although significant progr...

$3.65M
USD
Active NON-SBIR/STTR RPGS
Evaluating a remotely delivered, digital health CRC screening intervention among racially diverse patients of a community health center
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2028

Project Summary/Abstract Colorectal cancer (CRC) screening is one of the most effective tools to reduce cancer morbidity and mortality. Yet, CRC screening rates at federally qualif...

$5.77M
USD
Active NON-SBIR/STTR RPGS
Targeting PLK1 signaling for the treatment of fibrolamellar carcinoma
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

PROJECT SUMMARY Fibrolamellar carcinoma (FLC) is a childhood liver cancer with a high case mortality rate. Patients with FLC typically present with advanced disease, as there are n...

$4.5M
USD
Active NON-SBIR/STTR RPGS
Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

Project Summary Immune checkpoint blockade (ICB) targeting the PD-1/PD-L1 pathway has induced dramatic and durable clinical responses in melanoma and other cancers. Despite the suc...

$5.95M
USD
Active NON-SBIR/STTR RPGS
Exploring the Role of Nitrogen Metabolism in Cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2030

PROJECT SUMMARY/ABSTRACT There has been a renewed interest in how oncogenic driver mutations and tumor suppressor losses contribute to cancer-associated alterations in cellular met...

$10.09M
USD
Active NON-SBIR/STTR RPGS
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
NATIONAL CANCER INSTITUTE Children'S Hospital of Los Angeles United States 2023 – 2028

Project Summary There is a significant body of research into the genetic, genomic and epigenomic alterations of retinoblastoma (RB), a primary eye cancer that forms in the developi...

$5.36M
USD
Active NON-SBIR/STTR RPGS
Investigating the roles of oncogenic extrachromosomal circular DNAs in cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

ABSTRACT Increased oncogene expression mediated by focal amplifications is a common mechanism for oncogene activation in human cancers. Two major mechanisms leading to oncogene amp...

$5.38M
USD
Active NON-SBIR/STTR RPGS
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2023 – 2028

ABSTRACT Targeted cancer therapy, in the form of tyrosine kinase inhibitors, has been a game changer for patients with cancers driven by activating mutations in genes encoding thes...

$5.08M
USD
Active OTHER RESEARCH-RELATED
Assessment of a Radiomics-Based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT This proposal describes a comprehensive 5-year mentored career development plan with the goal of training the candidate to become a leading independent phy...

$2.5M
USD
Active NON-SBIR/STTR RPGS
Personalized neuroblastoma vaccines
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2023 – 2028

PROJECT SUMMARY This Multiple Principal Investigator (MPI) Project proposal for the Pediatric Immunotherapy Network is focused on high-risk neuroblastoma, a diverse and enigmatic m...

$7.77M
USD